New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their...('t surewhat their LDL ( bad cholesterol...)

Date:9/4/2007

't sure what their LDL ("bad" cholesterol) level is. This lack of knowledge may also affect cholesterol goals. Half don't have a total cholesterol goal and 79 percent don't have an LDL level goal. Further, about half of adults with high cholesterol (52 percent) do not believe their LDL cholesterol level is a serious risk to their health.

The 2007 high cholesterol survey, sponsored by Daiichi Sankyo, Inc., is a follow up to similar surveys conducted in 2000 and 2004.

"This survey demonstrates that despite all the information available today about high cholesterol, and the seriousness of health problems associated with elevated levels, many people don't seem to be making all the lifestyle changes necessary to address the problem. There is a significant gap between understanding the health risks associated with high cholesterol and knowing what their personal total and LDL cholesterol levels are, and the goals of treatment," said Peter H. Jones, MD, Baylor College of Medicine. "The survey also shows a need for physicians to communicate about treatment options and safety, including non-systemic or non-absorbed medications," added Dr. Jones.

Survey respondents said that important characteristics of a cholesterol- lowering medication are: that the medication is easy to tolerate (91 percent); that the medication can be used safely in combination with other drugs (89 percent); that the medication does not pass through their liver or kidneys (84 percent); and that the drug does not require blood work to monitor side effects of the liver (83 percent).

The leading class of non-systemic cholesterol-lowering medications is the bile acid sequestrant class (BAS). The branded leader of that class, WelChol(R), is an effective option with a well-established safety profile for patients with high LDL cholesterol.(3) WelChol differs from many other LDL cholesterol-lowering medications on the market because it is non-absorbed, meaning that the body does not absorb
'/>"/>

SOURCE Daiichi Sankyo, Inc. Copyright©2007 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7
Related biology technology :

1. Trace Analysis Optimizing Sensitivity Finnigan Surveyor PDA Detector
2. Accurate Evaluation of the Finnigan Surveyor Autosampler Performance using a Deferred Standard
3. Economic survey reveals better 2006 results
4. Survey company sells Wisconsin GIS piece
5. MoneyTree Survey reports no venture investment activity in Wisconin in Q2
6. Madison top-ranked In Digital Cities Survey
7. Student survey shows surging demand for wireless access
8. Galactic survey reveals a new look for the Milky Way
9. Two Wisconsin companies hold spots on Computerworld employee survey
10. Money Tree survey shows lull in Wisconsin venture capital deals
11. Survey of High Tech Company Leaders Points Out Need for Personal Growth